Home › Employers › CHRISTUS Mother Frances Hospital Jacksonville
CHRISTUS Mother Frances Hospital Jacksonville: H-1B salaries and sponsorship
CHRISTUS Mother Frances Hospital Jacksonville filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $72,800.
Does CHRISTUS Mother Frances Hospital Jacksonville sponsor H-1B visas?
CHRISTUS Mother Frances Hospital Jacksonville filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Feb 24, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Clinical Laboratory Scientist | 2 | $72,800 |
| Clinical Laboratory Scientist II | 1 | $72,800 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2025 | 3 | $72,800 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Clinical Laboratory Scientist II | $72,800 Level IV | Jacksonville, TX | Feb 24, 2025 | Mar 3, 2025 | Certified |
| Clinical Laboratory Scientist | $72,800 Level IV | Jacksonville, TX | Feb 20, 2025 | Mar 3, 2025 | Certified |
| Clinical Laboratory Scientist | $72,800 Level IV | Jacksonville, TX | Feb 20, 2025 | Mar 1, 2025 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).